Patents by Inventor Wlodzimierz Maslinski

Wlodzimierz Maslinski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antagonists of interleukin-15
    Patent number: 7834152
    Abstract: Disclosed herein are mutant IL-15 polypeptides and methods for using these polypeptides to modulate the immune response in a patient.
    Type: Grant
    Filed: March 20, 2007
    Date of Patent: November 16, 2010
    Assignee: Beth Israel Deaconess Medical Center, Inc.
    Inventors: Terry B. Strom, Wlodzimierz Maslinski
  • Compositions and methods for achieving immune suppression
    Patent number: 7347995
    Abstract: Disclosed herein are therapeutic compositions containing agents that modulate the immune response in a patient.
    Type: Grant
    Filed: May 25, 2004
    Date of Patent: March 25, 2008
    Assignee: Beth Israel Deaconess Medical Center, Inc.
    Inventors: Terry B. Strom, Wlodzimierz Maslinski, Xin Xiao Zheng, Yon Su Kim, Sylvie Ferrari-Lacraz
  • Antagonists of interleukin-15
    Publication number: 20080008680
    Abstract: Disclosed herein are mutant IL-15 polypeptides and methods for using these polypeptides to modulate the immune response in a patient.
    Type: Application
    Filed: March 20, 2007
    Publication date: January 10, 2008
    Inventors: Terry Strom, Wlodzimierz Maslinski
  • Antagonists of interleukin-15
    Patent number: 7258853
    Abstract: Disclosed herein are mutant IL-15 polypeptides and methods for using these polypeptides to modulate the immune response in a patient.
    Type: Grant
    Filed: September 17, 2002
    Date of Patent: August 21, 2007
    Assignee: Beth Israel Deaconess Medical Center, Inc.
    Inventors: Terry B. Strom, Wlodzimierz Maslinski
  • Nucleic acids encoding antagonists of interleukin-15
    Patent number: 6998476
    Abstract: Disclosure herein are mutant IL-15 polypeptides and methods for using these polypeptides to modulate the immune response in a patient.
    Type: Grant
    Filed: June 6, 2002
    Date of Patent: February 14, 2006
    Assignee: Beth Israel Deaconess Medical Center, Inc.
    Inventors: Terry B. Strom, Wlodzimierz Maslinski
  • NUCLEIC ACIDS ENCODING ANTAGONISTS OF INTERLEUKIN-15
    Publication number: 20050240010
    Abstract: Disclosure herein are mutant IL-15 polypeptides and methods for using these polypeptides to modulate the immune response in a patient.
    Type: Application
    Filed: June 6, 2002
    Publication date: October 27, 2005
    Inventors: Terry Strom, Wlodzimierz Maslinski
  • Compositions and methods for achieving immune suppression
    Publication number: 20040219148
    Abstract: Disclosed herein are therapeutic compositions containing agents that modulate the immune response in a patient.
    Type: Application
    Filed: May 25, 2004
    Publication date: November 4, 2004
    Applicant: Beth Israel Deaconess Medical Center, Inc., a Massachusetts corporation
    Inventors: Terry B. Strom, Wlodzimierz Maslinski, Xin Xiao Zheng, Yon Su Kim, Sylvie Ferrari-Lacraz
  • Compositions and methods for achieving immune suppression
    Patent number: 6797263
    Abstract: Disclosed herein are therapeutic compositions containing agents that modulate the immune response in a patient.
    Type: Grant
    Filed: May 14, 2001
    Date of Patent: September 28, 2004
    Assignee: Beth Israel Deaconess Medical Center, Inc.
    Inventors: Terry B. Strom, Wlodzimierz Maslinski, Xin Xiao Zheng, Yon Su Kim, Sylvie Ferrari-Lacraz
  • Antagonists of interleukin-15
    Publication number: 20030105295
    Abstract: Disclosed herein are mutant IL-15 polypeptides and methods for using these polypeptides to modulate the immune response in a patient.
    Type: Application
    Filed: September 17, 2002
    Publication date: June 5, 2003
    Applicant: Beth Israel Deaconess Medical Center, a Massachusetts corporation
    Inventors: Terry B. Strom, Wlodzimierz Maslinski
  • Antagonists of interleukin-15
    Patent number: 6451308
    Abstract: Disclosed herein are mutant IL-15 polypeptides and methods for using these polypeptides to modulate the immune response in a patient.
    Type: Grant
    Filed: November 9, 1999
    Date of Patent: September 17, 2002
    Assignee: Beth Israel Deaconess Medical Center
    Inventors: Terry B. Strom, Wlodzimierz Maslinski
  • Compositions and methods for achieving immune suppression
    Publication number: 20020128436
    Abstract: Disclosed herein are therapeutic compositions containing agents that modulate the immune response in a patient.
    Type: Application
    Filed: May 14, 2001
    Publication date: September 12, 2002
    Inventors: Terry B. Strom, Wlodzimierz Maslinski, Xin Xiao Zheng, Yon Su Kim, Sylvie Ferrari Lacraz
  • Compounds that inhibit the binding of RAF-1 or 14-3-3 proteins to the beta chain of IL-2 receptor, and pharmaceutical compositions containing same
    Patent number: 6281193
    Abstract: The invention relates to compounds, such as proteins, peptides and organic compounds, capable of blocking or inhibiting the binding interaction of Raf-1 or 14-3-3 proteins to the &bgr; chain of IL-2, and pharmaceutical compositions containing such compounds. In vitro assays for isolating, identifying and characterizing such compound capable of inhibiting interaction of Raf-1 or 14-3-3 proteins to IL-2&bgr; are also provided.
    Type: Grant
    Filed: March 8, 1999
    Date of Patent: August 28, 2001
    Assignee: Applied Research Systems ARS Holding N.V.
    Inventors: Terry Strom, Wlodzimierz Maslinski
  • COMPOUNDS THAT INHIBIT THE BINDING OF RAF-1 OR 14-3-3 PROTEINS TO THE BETA CHAIN OF IL-2 RECEPTOR, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
    Publication number: 20010016194
    Abstract: ? The invention relates to compounds, such as proteins, peptides and organic compounds, capable of blocking or inhibiting the binding interaction of Raf-1 or 14-3-3 proteins to the &bgr; chain of IL-2, and pharmaceutical compositions containing such compounds. In vitro assays for isolating, identifying and characterizing such compound capable of inhibiting interaction of Raf-1 or 14-3-3 proteins to IL-&bgr; are also provided.
    Type: Application
    Filed: March 8, 1999
    Publication date: August 23, 2001
    Inventors: TERRY STROM, WLODZIMIERZ MASLINSKI
  • Antagonists of interleukin-15
    Patent number: 6001973
    Abstract: Disclosed herein are mutant IL-15 polypeptides and methods for using these polypeptides to modulate the immune response in a patient.
    Type: Grant
    Filed: April 25, 1997
    Date of Patent: December 14, 1999
    Assignee: Beth Israel Deaconess Medical Center
    Inventors: Terry B. Strom, Wlodzimierz Maslinski